649 research outputs found

    Gangliosides for acute spinal cord injury.

    Get PDF
    BACKGROUND: Spinal cord injury (SCI) results in loss of feeling and movement. The consequences can be devastating for the patient and his or her carers. Global estimates of the number of new cases annually range from 15 to 40 per million. Leading causes of acute SCI are road traffic injury, violence, and injuries sustained in sports and other recreational activities. Care for people with SCI has improved, leading to an increase in survival rates. Attempts to improve patients' feeling and movement have involved the use of a wide range of treatments. Gangliosides are compounds that occur naturally in cell membranes. Laboratory studies have suggested they may have protective effects on nerves and even help them to re-grow. Clinical trials have taken place using gangliosides (usually GM1 ganglioside) for a number of neurological conditions. OBJECTIVES: To quantify the evidence for the effectiveness and safety of gangliosides when used to treat acute SCI. SEARCH STRATEGY: We searched the following databases to identify trials for inclusion: CENTRAL, MEDLINE, EMBASE, and the National Research Register. We also searched web-based trials registers, such as Current Controlled Trials. We approached the manufacturers of the most widely used ganglioside and researchers in this field to try to locate any unpublished data. SELECTION CRITERIA: Randomised controlled trials of any ganglioside versus controls, in patients with SCI. Outcome measures specified were: mortality, recovery of motor function, improvement in sensory measures, measures of functional activity, infections and any other adverse events. DATA COLLECTION AND ANALYSIS: Data were extracted from published studies and authors were contacted for further information. All data found was dichotomous and odds ratios (with 95% CIs) were calculated. A fixed-effects model was assumed. MAIN RESULTS: Two studies met the inclusion criteria. There were no deaths in one (n=37). In the other (n=760), there were slightly more deaths in the treatment group than in the control group; odds ratio 1.07 (0.57, 2.00 95%CI) - a result that can be explained by the play of chance. Methodological weaknesses regarding the collection and presentation of data from the two studies made it impossible to reach any conclusions regarding the effect of gangliosides on the other specified outcomes. AUTHORS' CONCLUSIONS: The evidence available does not support the use of ganglioside treatment to reduce the death rate in SCI patients. No evidence has yet emerged that ganglioside treatment improves recovery or quality of life in survivors

    Gifted Adults in the Workplace: A Systematic Literature Review

    Get PDF
    It is widely acknowledged amongst educators that gifted children have different needs requiring special consideration at school. However, little attention has been given to how these might manifest throughout a lifetime and in different contexts, such as the workplace. A systematic literature review was used to identify, collect, and summarise the current literature on this topic to provide direction for future research efforts. The review was conducted in accordance with the PRISMA statement for methodological rigour. Studies were included if they were discrete and presented findings that were specifically about gifted adults’ experiences in a work setting. The review did not consider studies that presented interpretations of others’ experiences such as those presented by clinicians or those relating to careers or career decisions. Literature was collected from the following databases: EBSCOhost megafile ultimate, Google Scholar, ProQuest, SAGE Journals, Scopus, Taylor & Francis, and Web of Science. JBI’s Critical Appraisal Tools were used to assess the quality and trustworthiness of the included studies. The PRISMA flow chart was used in conjunction with EndNote to document and manage the review. From the initial search, 754 records were screened and ultimately 19 studies were included in the review. The data in the included studies was subsequently analysed and coded in NVivo which identified twelve themes that could be categorised into three main groupings: the individual, the work, and others. For the individual category, the themes were skills and abilities, boredom, mental health and emotional wellbeing, self and identity, attitudes about work, past experiences and achievement. The themes relating to the work were the job and the workplace. For others, the themes were perception of the worker by others, interactions with others and social skills and abilities. The findings have implications for future research, gifted individuals, and their workplaces

    Heart Transplantation for Congenital Heart Disease in the First Year of Life

    Get PDF
    Successful infant heart transplantation has now been performed for over 25 years. Assessment of long term outcomes is now possible. We report clinical outcomes for322 patients who received their heart transplant during infancy. Actuarial graft survival for newborn recipients is 59% at 25 years. Survival has improved in the most recent era. Cardiac allograft vasculopathy is the most important late cause of death with an actuarial incidence at 25 years of 35%. Post-transplant lymphoma is estimated to occur in 20% of infant recipients by25 years. Chronic kidney disease grade 3 or worse is present in 31% of survivors. The epidemiology of infant heart transplantation has changed through the years as the results for staged repair improved and donor resources remained stagnant. Most centers now employ staged repair for hypoplastic left heart syndrome and similar extreme forms of congenital heart disease. Techniques for staged repair, including the hybrid procedure, are described. The lack of donors is described with particular note regarding decreased donors due to newer programs for appropriate infant sleep positioning and infant car seats. ABO incompatible donors are a newer resource for maximizing donor resources, as is donation after circulatory determination of death and techniques to properly utilize more donors by expanding the criteria for what is an acceptable donor. An immunological advantage for the youngest recipients has long been postulated, and evaluation of this phenomenon may provide clues to the development of accommodation and/or tolerance

    Role of mainstream flow velocity in film cooling in a duct

    Full text link
    Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/77235/1/AIAA-800-307.pd

    Toward a solution for cardiac failure in the newborn

    Full text link
    The newborn infant with severe cardiac failure owed to congenital structural heart disease or cardiomyopathy poses a daunting therapeutic challenge. The ideal solution for both might be cardiac transplantation if availability of hearts was not limiting and if tolerance could be induced, obviating toxicity of immunosuppressive therapy. If one could safely and effectively exploit neonatal tolerance for successful xenotransplantation of the heart, the challenge of severe cardiac failure in the newborn infant might be met. We discuss the need, the potential for applying neonatal tolerance in the setting of xenotransplantation and the possibility that other approaches to this problem might emerge.Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/146972/1/xen12479.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/146972/2/xen12479_am.pd

    Autonomous space processor for orbital debris advanced design project in support of solar system exploration

    Get PDF
    This paper is regarding a project in the Advanced Design Program at the University of Arizona. The project is named the Autonomous Space Processor for Orbital Debris (ASPOD) and is a NASA/Universities Space Research Association (USRA) sponsored design project. The development of ASPOD and the students' abilities in designing and building a prototype spacecraft are the ultimate goals of this project. This year's focus entailed the development of a secondary robotic arm and end-effector to work in tandem with an existent arm in the removal of orbital debris. The new arm features the introduction of composite materials and a linear drive system, thus producing a light-weight and more accurate prototype. The main characteristic of the end-effector design is that it incorporates all of the motors and gearing internally, thus not subjecting them to the harsh space environment. Furthermore, the arm and the end-effector are automated by a control system with positional feedback. This system is composed of magnetic and optical encoders connected to a 486 PC via two servo-motor controller cards. Programming a series of basic routines and sub-routines has allowed the ASPOD prototype to become more autonomous. The new system is expected to perform specified tasks with a positional accuracy of 0.5 cm
    corecore